MBCL-03. RESULTS OF HIGH-DOSE THIOTEPA, CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA

AIM: Medulloblastoma is a highly lethal disease when it recurs. Very few patients survive with second line conventional treatment after relapse. This study evaluated the use of high-dose thiotepa, carboplatin and etoposide with autologous hematopoietic stem-cell transplantation (HSCT) in patients wi...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Gevorgian, Asmik, Tolkunova, Polina, Kazantsev, Ilya, Iukhta, Tatiana, Kozlov, Andrew, Zvyagintseva, Darya, Morozova, Elena, Zubarovskaya, Ludmila, Afanasiev, Boris, Zheludkova, Olga, Punanov, Yury
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Medulloblastoma (Clinical)
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715147/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.479
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料